BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31211478)

  • 21. Ginsenoside Rh2 Inhibited Proliferation by Inducing ROS Mediated ER Stress Dependent Apoptosis in Lung Cancer Cells.
    Ge G; Yan Y; Cai H
    Biol Pharm Bull; 2017 Dec; 40(12):2117-2124. PubMed ID: 28966297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ginsenoside Rh2 Targets EGFR by Up-Regulation of miR-491 to Enhance Anti-tumor Activity in Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Chen W; Qiu Y
    Cell Biochem Biophys; 2015 Jun; 72(2):325-31. PubMed ID: 25561284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effects by oral administration of ginsenoside Rh2 on the growth of human ovarian cancer cells in nude mice.
    Tode T; Kikuchi Y; Kita T; Hirata J; Imaizumi E; Nagata I
    J Cancer Res Clin Oncol; 1993; 120(1-2):24-6. PubMed ID: 8270603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/interferon-gamma-stimulated BV-2 microglial cells.
    Bae EA; Kim EJ; Park JS; Kim HS; Ryu JH; Kim DH
    Planta Med; 2006 Jun; 72(7):627-33. PubMed ID: 16673329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ginsenoside Rh2 attenuates allergic airway inflammation by modulating nuclear factor-κB activation in a murine model of asthma.
    Li LC; Piao HM; Zheng MY; Lin ZH; Choi YH; Yan GH
    Mol Med Rep; 2015 Nov; 12(5):6946-54. PubMed ID: 26502836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells.
    Cheng CC; Yang SM; Huang CY; Chen JC; Chang WM; Hsu SL
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):531-40. PubMed ID: 15739095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary study on fabrication, characterization and synergistic anti-lung cancer effects of self-assembled micelles of covalently conjugated celastrol-polyethylene glycol-ginsenoside Rh2.
    Li P; Zhou X; Qu D; Guo M; Fan C; Zhou T; Ling Y
    Drug Deliv; 2017 Nov; 24(1):834-845. PubMed ID: 28532223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A FASN-TGF-β1-FASN regulatory loop contributes to high EMT/metastatic potential of cisplatin-resistant non-small cell lung cancer.
    Yang L; Zhang F; Wang X; Tsai Y; Chuang KH; Keng PC; Lee SO; Chen Y
    Oncotarget; 2016 Aug; 7(34):55543-55554. PubMed ID: 27765901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ginsenoside Rh2 reverses sleep deprivation-induced cognitive deficit in mice.
    Lu C; Wang Y; Lv J; Jiang N; Fan B; Qu L; Li Y; Chen S; Wang F; Liu X
    Behav Brain Res; 2018 Sep; 349():109-115. PubMed ID: 29544964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ginsenoside Rh2 Inhibits Angiogenesis in Prostate Cancer by Targeting CNNM1.
    Huang Y; Huang H; Han Z; Li W; Mai Z; Yuan R
    J Nanosci Nanotechnol; 2019 Apr; 19(4):1942-1950. PubMed ID: 30486934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
    Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
    Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatty acid synthase promoter: characterization, and transcriptional regulation by sterol regulatory element binding protein-1 in goat mammary epithelial cells.
    Li J; Luo J; Xu H; Wang M; Zhu J; Shi H; Haile AB; Wang H; Sun Y
    Gene; 2015 Apr; 561(1):157-64. PubMed ID: 25688876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of the Rare Ginsenoside Rh2-MIX (20(
    Song BK; Kim KM; Choi KD; Im WT
    J Microbiol Biotechnol; 2017 Jul; 27(7):1233-1241. PubMed ID: 28478658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ginsenoside Rg3 sensitizes human non-small cell lung cancer cells to γ-radiation by targeting the nuclear factor-κB pathway.
    Wang L; Li X; Song YM; Wang B; Zhang FR; Yang R; Wang HQ; Zhang GJ
    Mol Med Rep; 2015 Jul; 12(1):609-14. PubMed ID: 25738799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of 20 (S) -ginsenoside Rh2 and 20 (R) -ginsenoside Rh2 on proliferation and apoptosis of human lung adenocarcinoma A549 cells].
    Zhang C; Yu H; Hou J
    Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(12):1670-4. PubMed ID: 22007558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone modifications in FASN modulated by sterol regulatory element-binding protein 1c and carbohydrate responsive-element binding protein under insulin stimulation are related to NAFLD.
    Du X; Cai C; Yao J; Zhou Y; Yu H; Shen W
    Biochem Biophys Res Commun; 2017 Jan; 483(1):409-417. PubMed ID: 28027934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Inhibitory effects of oral administration of ginsenoside Rh2 on tumor growth in nude mice bearing serous cyst adenocarcinoma of the human ovary].
    Tode T; Kikuchi Y; Hirata J; Kita T; Imaizumi E; Nagata I
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Nov; 45(11):1275-82. PubMed ID: 8258727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ginsenoside Rh2 enhances the antitumor immunological response of a melanoma mice model.
    Wang M; Yan SJ; Zhang HT; Li N; Liu T; Zhang YL; Li XX; Ma Q; Qiu XC; Fan QY; Ma BA
    Oncol Lett; 2017 Feb; 13(2):681-685. PubMed ID: 28356946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ginsenoside-Rh1 and Rh2 inhibit the induction of nitric oxide synthesis in murine peritoneal macrophages.
    Park YC; Lee CH; Kang HS; Kim KW; Chung HT; Kim HD
    Biochem Mol Biol Int; 1996 Nov; 40(4):751-7. PubMed ID: 8950033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nootkatone, an AMPK activator derived from grapefruit, inhibits KRAS downstream pathway and sensitizes non-small-cell lung cancer A549 cells to adriamycin.
    Hung LVM; Moon JY; Ryu JY; Cho SK
    Phytomedicine; 2019 Oct; 63():153000. PubMed ID: 31280139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.